Capital, Entrepreneurs, Investment, Uncategorized 01.21.21 i2E Primary Source of Investment Capital Read more
News 09.20.19 Oklahoma-based Kirrhos Pharmaceuticals tackles fatty liver disease known as NASH Read more
Featured, News 09.12.19 i2E Inc. leads $850,000 investment in Oklahoma-based Kirrhos Pharmaceuticals Read more